Correlation Between Johnson Johnson and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Allovir, you can compare the effects of market volatilities on Johnson Johnson and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Allovir.

Diversification Opportunities for Johnson Johnson and Allovir

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Johnson and Allovir is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Allovir go up and down completely randomly.

Pair Corralation between Johnson Johnson and Allovir

Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.11 times more return on investment than Allovir. However, Johnson Johnson is 9.49 times less risky than Allovir. It trades about -0.25 of its potential returns per unit of risk. Allovir is currently generating about -0.07 per unit of risk. If you would invest  16,566  in Johnson Johnson on September 16, 2024 and sell it today you would lose (1,904) from holding Johnson Johnson or give up 11.49% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Johnson Johnson  vs.  Allovir

 Performance 
       Timeline  
Johnson Johnson 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest uncertain performance, the Stock's basic indicators remain steady and the new chaos on Wall Street may also be a sign of medium-term gains for the company stakeholders.
Allovir 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allovir has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Johnson Johnson and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Johnson Johnson and Allovir

The main advantage of trading using opposite Johnson Johnson and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
The idea behind Johnson Johnson and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Directory
Find actively traded commodities issued by global exchanges